Code | CSB-EP865133HU1 |
Abbreviation | Recombinant Human TREX1 protein, partial |
MSDS | |
Size | US$306 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
The gene fragment corresponding to the 1-242aa of the human TREX1 protein was synthesized, with appropriate restriction sites suitable for in-frame cloning into an expression vector, with N-terminal 10xHis tag and C-terminal Myc tag. The E.coli was transformed with the expression vector, and the clone was expressed upon certain induction. After the induced cell centrifugation, the recombinant protein was purified from the cell extract and presented as N-terminal 10xHis-tagged and C-terminal Myc-tagged fusion. This recombinant human TREX1 protein's purity is greater than 85% assayed by SDS-PAGE. The TREX1 protein ran to a band of about 33 kDa molecular weight on the gel, indicating a glycosylated form of the protein.
TREX1 is a member of the DEDD family of 3’ → 5’, whose members are defined by a conserved Asp-Glu-Asp-Asp motif that facilitates catalytic activity. Members of the DEDD nuclease family frequently have a role in DNA replication and/or repair. More than sixty TREX1 mutations have now been identified that exhibit dominant and recessive genetics and occur as inherited or de novo mutations, dependent upon the specific mutant allele. TREX1 disease alleles include missense mutations, insertions, duplications, and frame shifts that locate to positions throughout the 314-amino acid-coding gene. There is a causal relationship between TREX1 genetic variants and multiple mechanisms of TREX1 enzyme dysfunction that have now been linked to a spectrum of autoimmune diseases in human. Most of the TREX1 mutations affecting the catalytic domain are recessive and are largely associated with Aicardi-Goutières Syndrome (AGS) or Familial Chilblains Lupus (FCL).
There are currently no reviews for this product.